Clinical Trials Directory

Trials / Completed

CompletedNCT04945408

Longitudinal Description of Hemorrhoidal Pathology

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hemorrhoidal disease is a common cause of gastroenterology visits. In the United States, it is considered the 3rd most common gastrointestinal diagnosis with nearly 4 million scheduled or emergency visits. In France, self-reported questionnaires estimate that one person in five has suffered at least one hemorrhoidal attack in the past year.

Detailed description

Hemorrhoidal disease significantly alters the quality of life, can be life threatening in case of heavy bleeding and has a significant economic impact. However, there are still many unknowns regarding the different types of hemorrhoidal disease, its symptoms, its natural history, its etiology, its triggering and promoting factors, the associated pathologies, the therapeutic indications, etc. In addition, the therapeutic management is not consensual, especially since the therapeutic arsenal is constantly expanding over the last 20 years with the advent of minimally invasive surgical techniques. The aim of the work is to answer some of these questions on the basis of a prospective cohort of patients.

Conditions

Timeline

Start date
2020-06-15
Primary completion
2021-06-15
Completion
2023-03-06
First posted
2021-06-30
Last updated
2023-03-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04945408. Inclusion in this directory is not an endorsement.

Longitudinal Description of Hemorrhoidal Pathology (NCT04945408) · Clinical Trials Directory